Sonali Das
Kharagpur, WB 721302, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Systems-Integrated Thermostable Vaccine Delivery: Converging Cold-Chain-Free Design, AI-Augmented Formulation, and Climate-Resilient Infrastructure.
Journal: Molecular pharmaceutics
Published: October 30, 2025
Discovery of 1-(Cyclopropylmethyl)-2-(Dibenzo[b,d]Thiophen-2-yl)-1H-Benzo[d]Imidazole-5-Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist.
Journal: Chemical biology & drug design
Published: May 09, 2025
Assessment of nutritional status among post-kala-azar dermal leishmaniasis patients in endemic areas of northern West Bengal, India.
Journal: Tropical parasitology
Published: September 28, 2024
Novel Pyrido[2',1':2,3]imidazo[4,5-c]quinoline Derivative Selectively Poisons Leishmania donovani Bisubunit Topoisomerase 1 to Inhibit the Antimony-Resistant Leishmania Infection in Vivo.
Journal: Journal of medicinal chemistry
Published: February 24, 2023
The paradigm of intracellular parasite survival and drug resistance in leishmanial parasite through genome plasticity and epigenetics: Perception and future perspective.
Journal: Frontiers in cellular and infection microbiology
Published: July 24, 2022
The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.
Journal: Virulence
Published: May 09, 2022
Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy.
Journal: Frontiers in cellular and infection microbiology
Published: April 06, 2022
Revealing a Novel Antigen Repressor of Differentiation Kinase 2 for Diagnosis of Human Visceral Leishmaniasis in India.
Journal: Pathogens (Basel, Switzerland)
Published: October 29, 2021
A comprehensive review of various categories of face masks resistant to Covid-19.
Journal: Clinical epidemiology and global health
Published: March 30, 2021
A chemical inhibitor of heat shock protein 78 (HSP78) from Leishmania donovani represents a potential antileishmanial drug candidate.
Journal: The Journal of biological chemistry
Published: May 27, 2020
Last Updated: 09/26/2026